Here's my take on warrants: The change in warrant price and expiration date helps those big investors that bought into offerings that raised money for CVM in years past. It helps keep their warrants viable. In the end, if exercised, they will raise money for the company. Those warrants were adversely affected by reverse splits, etc., but this helps make them viable again. CVM would not give them only a month's extension at a price that high, $13.75, if they were not confident that the stock will be worth more than that by June 25, 2020 making the exercise of the warrants worth exercising. This is a positive and so is the other news on past warrants. If I had some of those warrants, I would be thankful for this change. It will offset some the lose from the stock that was also purchased at the time of the offering. It reflects the confidence of the company regarding the data for Multikine. This is a buying opportunity in my opinion.